During the corresponding time, Pure Bioscience Inc recorded a revenue increase by 3.05 % year on year, sequentially revenue grew by 13.96 %. While revenue at the Pure Bioscience Inc 's corporate clients
Pure Bioscience Inc's Comment on Sales, Marketing and Customers
The company provides antimicrobial products to customers and third-party distributors across multiple industries. Its patented molecule, SDC, serves as an antimicrobial agent in various products marketed in diverse sectors. The company operates in the U.S. food industry, addressing limitations of existing food safety solutions and the use of toxic chemicals in food processing. Its products offer a non-toxic alternative for food processing and other applications.
In a decisive move to bolster its market presence and expand its distribution channel, PURE Bioscience, Inc. (OTCQB: PURE), a pioneer in non-toxic antimicrobial solutions, has announced three significant distribution agreements with renowned companies: Hydrite Chemical Company, AFCO (a Zep Company), and Quip Laboratories, Inc. Key Facts: 1. Nature of Agreements : - PURE Bioscience has entered into multi-year distribution agreements that allow for the purchase and sale of its flagship product, silver dihydrogen citrate (SDC), under specially negotiated terms and conditions. 2. Distribution Partners : - The agreements involve respected entities in the cleaning and sanitation industry: - Hyd...
In the evolving world of antimicrobial solutions, PURE Bioscience stands at the forefront with its innovative, non-toxic silver dihydrogen citrate (SDC) technology. Known for its potential to revolutionize sanitation across various sectors, SDC products are gaining attention for their unparalleled effectiveness and safety profile. PURE Bioscience has recently solidified its market position through a decisive multi-year distribution agreement with Quip Laboratories, a prominent entity in sanitation solutions. Key Facts of the Agreement The partnership between PURE Bioscience and Quip Laboratories is poised to create ripples across the sanitation and bioscience industries. Quip Labs will now have exclusive rig...
PURE Bioscience Expands Market Reach Through Strategic Distribution Agreements and Reports Strong Financial Growth El Cajon, Calif. - PURE Bioscience, Inc. (OTCQB: PURE), renowned for its innovation in antimicrobial technology, has recently made significant strides in expanding its market presence through two pivotal agreements: a multi-year distribution agreement with ChemStation and an international supply and license agreement with AgroVet Alliance. These strategic partnerships not only bolster the distribution capabilities of PURE’s patented silver dihydrogen citrate (SDC) products but also reflect the company s commitment to leveraging its groundbreaking non-toxic antimicrobial technology in various ...
PURE Bioscience and AgroVet Alliance Collaborate on International Supply and License Agreement By CSIMarket.com EL CAJON, Calif. PURE Bioscience, Inc. (OTCQB: PURE), the developer of the innovative non-toxic silver dihydrogen citrate (SDC) antimicrobial, has entered into a multi-year international supply and license agreement with AgroVet Alliance, FZE (AVA). This strategic partnership aims to expand the distribution and utilization of SDC products across the global animal health and livestock markets.Jeff Kitchell, Vice President of Operations for PURE, expressed optimism about the agreement, noting that AVA brings extensive experience in the global animal health sector. AVA has been doing business world...
In a recent financial report, PURE Bioscience, Inc. (PURE), a California-based company known for its innovative non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced its impressive fiscal third-quarter results for the period ending April 30, 2024. The report highlights the company s continuous growth and increased net product sales, showcasing the effectiveness and market demand for PURE s groundbreaking solution.During the fiscal third quarter, PURE recorded net product sales of $440,000, reflecting a significant increase compared to the previous year s sales of $406,000. This growth of $34,000 can be primarily attributed to the expanding demand for PURE s SDC antimicrobial in various industrie...
EL CAJON, Calif. - PURE Bioscience, Inc. (OTCQB: PURE), a leading provider of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced its financial results for the fiscal third quarter ended April 30, 2024. Despite facing external challenges, the company demonstrated its resilience with impressive net product sales of $440,000, representing a $34,000 increase compared to the previous year.PURE Bioscience s success can be attributed to the growing demand for its innovative SDC antimicrobial solution. This solution has gained recognition for being highly effective while also being safe for human use and the environment. As society becomes more conscious of the need for sustainable and n...
Pure Bioscience Inc’s Comment on Sales, Marketing and Customers
The company provides antimicrobial products to customers and third-party distributors across multiple industries. Its patented molecule, SDC, serves as an antimicrobial agent in various products marketed in diverse sectors. The company operates in the U.S. food industry, addressing limitations of existing food safety solutions and the use of toxic chemicals in food processing. Its products offer a non-toxic alternative for food processing and other applications.
Sources:
Pure Bioscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pure Bioscience Inc’s corporate clients.
For your research, we’ve provided 9 tables on Pure Bioscience Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
18.18 %